Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-23-009974

Chief Medical Officer gave up 2,183 shares (to pay taxes)

  • Chief Medical Officer acquired 1,296 shares (grant or award)
  • Chief Medical Officer acquired 6,166 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Harris Matthew Scott Chief Medical Officer 2023-01-31 Grant or award +1,296 $10.21 $13,230 13,917 D: show line 1 in the form
Harris Matthew Scott Chief Medical Officer 2023-02-01 Option exercise +6,166 20,083 D: show line 2 in the form
Harris Matthew Scott Chief Medical Officer 2023-02-01 Shares withheld for taxes −2,183 $13.78 $30,082 17,900 D: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Harris Matthew Scott Chief Medical Officer 2023-02-01 Option exercise · Restricted Stock Units −6,166 12,332 D: show line 4 in the form
Loading xslF345X03/tm235311-3_4seq1.xml…